| 000 | 01835 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516005316.0 | ||
| 264 | 0 | _c20110405 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1932-8737 | ||
| 024 | 7 |
_a10.1002/clc.20830 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPepine, Carl J | |
| 245 | 0 | 0 |
_aCombination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies. _h[electronic resource] |
| 260 |
_bClinical cardiology _cOct 2010 |
||
| 300 |
_a609-619 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenofibrate _xadministration & dosage |
| 650 | 0 | 4 |
_aFluorobenzenes _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 | _aRosuvastatin Calcium |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJacobson, Terry A | |
| 700 | 1 | _aCarlson, Dawn M | |
| 700 | 1 | _aKelly, Maureen T | |
| 700 | 1 | _aSetze, Carolyn M | |
| 700 | 1 | _aGold, Alex | |
| 700 | 1 | _aStolzenbach, James C | |
| 700 | 1 | _aWilliams, Laura A | |
| 773 | 0 |
_tClinical cardiology _gvol. 33 _gno. 10 _gp. 609-619 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/clc.20830 _zAvailable from publisher's website |
| 999 |
_c20263321 _d20263321 |
||